Monitoring the development of resistance to the novel insecticide clothianidin in Anopheles gambiae

监测冈比亚按蚊对新型杀虫剂噻虫胺的抗药性发展

基本信息

项目摘要

Project Summary/Abstract Despite ongoing efforts to diversify malaria control interventions with new technologies such as the use of transgenic mosquitoes to suppress or replace wild vector populations, insecticides remain the cornerstone of strategies aimed at reducing the global burden of this disease. In sub-Saharan Africa in particular, the massive deployment of long-lasting insecticidal nets and indoor residual spraying has contributed to a significant reduction in malaria incidence in just two decades. For this reason, the development of insecticide resistance currently observed among vector populations is regarded as a very serious thread that can quickly undermine recent gains in malaria control. To preserve the effectiveness of insecticides used for malaria vector control, target interventions informed by sufficient knowledge of the susceptibility profile of local populations are more than crucial. Our project aims to study the development of resistance to clothianidin, a new insecticide recently approved for indoor residual spraying. To achieve our goal, we will capitalize on an international collaboration between Liverpool School of Topical Medicine in the UK, Centre for Research in Infectious Diseases in Cameroon as well as notional and international partners directly involved in the fight against malaria in Cameroon. This collaboration will foster capacity building and transfer of technologies in order to promote the use state- of-the-art genomic and functional genomic tools to address the underpinnings of insecticide resistance in malaria vectors in endemic countries. The specific aims of our project are: 1) to monitor the susceptibility of An. gambiae to clothianidin in Cameroon, 2) to evaluate the development and establishment of resistance in clothianidin-selected populations of An. gambiae, and 3) to determine the genetic loci underlying resistance to clothianidin. !
项目总结/摘要 尽管正在努力使疟疾控制干预措施多样化, 技术,如使用转基因蚊子来抑制或取代 野生病媒种群,杀虫剂仍然是战略的基石, 减少这种疾病的全球负担。特别是在撒哈拉以南非洲, 大规模部署长效驱虫蚊帐和室内残留杀虫剂, 喷洒药物在仅仅两个国家就大大降低了疟疾发病率, 几十年因此,目前杀虫剂抗性的发展 在病媒种群中观察到的这一现象被认为是一个非常严重的问题, 迅速破坏最近在疟疾控制方面取得的成果。为了保持 用于疟疾病媒控制的杀虫剂, 对当地人群易感性的充分了解, 比至关重要。我们的项目旨在研究抗 噻虫胺,一种新的杀虫剂,最近批准用于室内残留喷洒。到 为了实现我们的目标,我们将利用国际合作, 英国利物浦局部医学院传染病研究中心 喀麦隆以及名义上和国际伙伴直接 在喀麦隆参与抗击疟疾的工作。这一合作将促进 能力建设和技术转让,以促进国家- 最先进的基因组和功能基因组工具,以解决基础的 疟疾流行国家疟疾病媒对杀虫剂的抗药性。具体目标 本课题的主要内容是:1)监测安氏杆菌的易感性。冈比亚对噻虫胺 喀麦隆,2)评估在非洲大陆上抗药性的发展和建立, 噻虫胺选择的An.冈比亚,和3)确定遗传 对噻虫胺耐药的基因座。 !

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Basile Kamgang其他文献

Basile Kamgang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Basile Kamgang', 18)}}的其他基金

Monitoring the development of resistance to the novel insecticide clothianidin in Anopheles gambiae
监测冈比亚按蚊对新型杀虫剂噻虫胺的抗药性发展
  • 批准号:
    10622489
  • 财政年份:
    2020
  • 资助金额:
    $ 13.5万
  • 项目类别:

相似海外基金

A mixed methods approach to address multi-level barriers to care for migratory men living with HIV in South Africa
采用混合方法解决照顾南非艾滋病毒携带者移民男性的多层次障碍
  • 批准号:
    10403224
  • 财政年份:
    2022
  • 资助金额:
    $ 13.5万
  • 项目类别:
Using the EPIC model to build transdisciplinary communities of practice that effectively address urban resilience in Africa and Asia
使用 EPIC 模型建立跨学科实践社区,有效解决非洲和亚洲的城市复原力问题
  • 批准号:
    2103692
  • 财政年份:
    2022
  • 资助金额:
    $ 13.5万
  • 项目类别:
    Standard Grant
A mixed methods approach to address multi-level barriers to care for migratory men living with HIV in South Africa
采用混合方法解决照顾南非艾滋病毒携带者移民男性的多层次障碍
  • 批准号:
    10689689
  • 财政年份:
    2022
  • 资助金额:
    $ 13.5万
  • 项目类别:
Complex intervention to optimise adolescent BMI pre-conception to address the double burden of malnutrition: A RCT in rural and urban South Africa
优化青少年孕前体重指数以解决营养不良的双重负担的复杂干预措施:南非农村和城市的随机对照试验
  • 批准号:
    MR/V005790/1
  • 财政年份:
    2021
  • 资助金额:
    $ 13.5万
  • 项目类别:
    Research Grant
Complex intervention to optimise adolescent BMI pre-conception to address the double burden of malnutrition: A RCT in rural and urban South Africa
优化青少年孕前体重指数以解决营养不良的双重负担的复杂干预措施:南非农村和城市的随机对照试验
  • 批准号:
    MR/V005790/2
  • 财政年份:
    2021
  • 资助金额:
    $ 13.5万
  • 项目类别:
    Research Grant
An implementation science approach to address multi-level barriers to cancer screening among women living with HIV in South Africa
一种实施科学方法,以解决南非艾滋病毒感染妇女癌症筛查的多层次障碍
  • 批准号:
    10242935
  • 财政年份:
    2020
  • 资助金额:
    $ 13.5万
  • 项目类别:
A Multisectoral Strategy to Address Persistent Drivers of the HIV Epidemic in East Africa
解决东非艾滋病毒流行的持续驱动因素的多部门战略
  • 批准号:
    10267216
  • 财政年份:
    2020
  • 资助金额:
    $ 13.5万
  • 项目类别:
A Multisectoral Strategy to Address Persistent Drivers of the HIV Epidemic in East Africa
解决东非艾滋病毒流行的持续驱动因素的多部门战略
  • 批准号:
    10085144
  • 财政年份:
    2020
  • 资助金额:
    $ 13.5万
  • 项目类别:
A Multisectoral Strategy to Address Persistent Drivers of the HIV Epidemic in East Africa
解决东非艾滋病毒流行的持续驱动因素的多部门战略
  • 批准号:
    10438844
  • 财政年份:
    2020
  • 资助金额:
    $ 13.5万
  • 项目类别:
Teaching empowerment: Grass-roots educators' strategies to address gender equity in the context of the HIV epidemic in South Africa
教学赋权:基层教育工作者在南非艾滋病毒流行背景下解决性别平等问题的战略
  • 批准号:
    218055
  • 财政年份:
    2010
  • 资助金额:
    $ 13.5万
  • 项目类别:
    Studentship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了